Tag Archives: Approved

Brukinsa Approved for Relapsed, Refractory Mantle Cell Lymphoma

MONDAY, Nov. 18, 2019 — Brukinsa (zanubrutinib), a kinase inhibitor, has been granted accelerated approval for the treatment of adults with mantle cell lymphoma who have received at least one previous therapy, the U.S. Food and Drug Administration announced last week. The recommended dose of Brukinsa capsules is 160 mg orally twice daily or 320… Read More »

New Drug Approved for Traveler's Diarrhea

Nov. 20, 2018 — The FDA has approved a new prescription drug for traveler’s diarrhea, which affects millions of people a year, cutting short vacations and other trips. Rifamycin (Aemcolo) is expected to be on the market by mid-February, says Tom Joyce, president and CEO of Aries Pharmaceuticals, the U.S. firm licensed to distribute it… Read More »